0001567619-20-002450.txt : 20200207
0001567619-20-002450.hdr.sgml : 20200207
20200207170054
ACCESSION NUMBER: 0001567619-20-002450
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200205
FILED AS OF DATE: 20200207
DATE AS OF CHANGE: 20200207
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MAZELSKY JONATHAN JAY
CENTRAL INDEX KEY: 0001556270
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19271
FILM NUMBER: 20588243
MAIL ADDRESS:
STREET 1: ONE IDEXX DRIVE
CITY: WESTBROOK
STATE: ME
ZIP: 04092
FORMER NAME:
FORMER CONFORMED NAME: MAZELSKY JAY
DATE OF NAME CHANGE: 20120815
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IDEXX LABORATORIES INC /DE
CENTRAL INDEX KEY: 0000874716
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 010393723
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE IDEXX DRIVE
CITY: WESTBROOK
STATE: ME
ZIP: 04092-2041
BUSINESS PHONE: 2075560300
MAIL ADDRESS:
STREET 1: ONE IDEXX DRIVE
CITY: WESTBROOK
STATE: ME
ZIP: 04092-2041
FORMER COMPANY:
FORMER CONFORMED NAME: IDEXX CORP / DE
DATE OF NAME CHANGE: 19600201
4
1
doc1.xml
FORM 4
X0306
4
2020-02-05
0
0000874716
IDEXX LABORATORIES INC /DE
IDXX
0001556270
MAZELSKY JONATHAN JAY
ONE IDEXX DRIVE
WESTBROOK
ME
04092
1
1
0
0
President & CEO
Common Stock
2020-02-05
4
M
0
13824
45.84
A
50685
D
Common Stock
2020-02-05
4
S
0
1145
275.7245
D
49540
D
Common Stock
2020-02-05
4
S
0
1337
276.7072
D
48203
D
Common Stock
2020-02-05
4
S
0
3354
277.8769
D
44849
D
Common Stock
2020-02-05
4
S
0
1676
279.0054
D
43173
D
Common Stock
2020-02-05
4
S
0
100
280.133
D
43073
D
Common Stock
2020-02-05
4
S
0
388
281.9705
D
42685
D
Non-Qualified Stock Option (right-to-buy)
45.84
2020-02-05
4
M
0
13824
D
2020-02-13
Common Stock
13824
0
D
Transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
Represents the weighted average price of the shares sold ranging from a low of $275.24 to a high of $276.21 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Represents the weighted average price of the shares sold ranging from a low of $276.30 to a high of $277.27 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Represents the weighted average price of the shares sold ranging from a low of $277.50 to a high of $278.48 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Represents the weighted average price of the shares sold ranging from a low of $278.655 to a high of $279.642 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Represents the weighted average price of the shares sold ranging from a low of $281.87 to a high of $282.00 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
Grant of option to buy 13,014 shares of Issuer common stock that became exercisable in five annual installments beginning February 14, 2014 without giving effect to the 2-for-1 stock split of IDEXX Laboratories, Inc. common stock that occurred on June 15, 2015 (the "Stock Split"). The number of derivative securities reported as beneficially owned with respect to this option and its exercise price were adjusted to reflect the Stock Split.
Not applicable.
/s/ Lily J. Lu, Attorney-in-Fact for Jonathan Jay Mazelsky
2020-02-07